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Immortalized human lymphoblastoid cell lines have been used
to demonstrate that it is possible to use an in vitro model system to
identify genetic factors that affect responses to xenobiotics. To
extend the application of such studies to investigative toxicology
by assessing interindividual and population-wide variability and
heritability of chemical-induced toxicity phenotypes, we have
used cell lines from the Centre d’Etude du Polymorphisme
Humain (CEPH) trios assembled by the HapMap Consortium.
Our goal is to aid in the development of predictive in vitro
genetics-anchored models of chemical-induced toxicity. Cell lines
from the CEPH trios were exposed to three concentrations of 14
environmental chemicals. We assessed ATP production and
caspase-3/7 activity 24 h after treatment. Replicate analyses were
used to evaluate experimental variability and classify responses.
We show that variability of response across the cell lines exists for
some, but not all, chemicals, with perfluorooctanoic acid (PFOA)
and phenobarbital eliciting the greatest degree of interindividual
variability. Although the data for the chemicals used here do not
show evidence for broad-sense heritability of toxicity response
phenotypes, substantial cell line variation was found, and
candidate genetic factors contributing to the variability in
response to PFOA were investigated using genome-wide associa-
tion analysis. The approach of screening chemicals for toxicity in
a genetically defined yet diverse in vitro human cell-based system
is potentially useful for identification of chemicals that may pose
a highest risk, the extent of within-species variability in the
population, and genetic loci of interest that potentially contribute
to chemical susceptibility.
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Environmental and public health agencies are faced with the
overwhelming task of assessing the human risk from tens of
thousands of chemicals that are released in the environment
each year (Judson et al., 2009). Traditional approaches to
toxicity characterization rely on extensive animal testing, cost
millions of dollars, can take many years per chemical, and have
significant uncertainty factors. Because of the time consuming
and costly nature of in vivo testing, data currently exist for only
a small fraction of the chemicals of potential concern (Judson
et al., 2009). The National Research Council report (NRC,
2007) argues for a transition from in vivo models to in vitro/
in silico methods in order to capitalize on the advances in
technology and computational biology to more efficiently and
effectively predict human health risk and reduce the time and
cost of testing. Governmental agencies in the United States
have responded by initiating large-scale high-throughput
screening programs, devising methods to coordinate data, and
considering modified approaches to risk assessment (Collins
et al., 2008).
To address the pressures for more efficient risk assessment
and prioritization strategies, there is a need for in vitro toxicity
testing in population-based models (NRC, 2008). Although
genetic information can play a key role in understanding and
quantifying human susceptibility, an essential step in many of
the risk assessments used to shape policy (Cullen et al., 2008),
traditional toxicity testing paradigms do not address this critical
need. Toxicity data derived from studies on lower organisms
(such as yeast), only a single cell line, or rodent strain cannot
be used to understand how constitutional genetic variation
between individuals in a human population may affect toxicity
(Rusyn et al., 2010). In the absence of an understanding of
population genetic variation, default uncertainty factors, rather
than scientific data, drive risk assessment decisions on most
chemicals. Better population-based, genetically defined models
are needed to fill these data gaps and to develop more
meaningful uncertainty factors.
Recent studies using immortalized human lymphoblastoid
cell lines (LCLs) from the International HapMap Consortium
show promise in filling this gap with meaningful data. This
in vitro population-based model has been used successfully to
evaluate interindividual and gender-specific differences in
responses to drugs (Dolan et al., 2004; Watters et al., 2004)
and to identify genes in the transcriptional response to
radiation, including genes involved in cell cycle control,
DNA repair, and cell death (Jen and Cheung, 2003). HapMap
cell lines of Northern and Western European ancestry (CEU)
are arranged in family trios, have been densely genotyped
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(Frazer et al., 2007), and provide large, renewable sample sets
for a wide range of studies (Meucci et al., 2005). Although
HapMap cell lines have important limitations (Choy et al.,
2008), we hypothesized that a population-based human in vitro
model may be used for assessment of interindividual and
population-wide variability in chemical-induced toxicity phe-
notypes and provide information for the biological interpreta-
tion of the variability.
The Centre d’Etude du Polymorphisme Humain (CEPH)
panel of LCL trios was treated with 14 model environmental
toxicants, and two widely used markers (Huang et al., 2008;
Xia et al., 2008) of cell death/viability (ATP production and
caspase-3/7 activity) were used to assess toxicity. We show that
this in vitro genetics-anchored human model system can be
used to demonstrate (1) the utility of a population-based
approach to screening for chemical toxicity and (2) the
potential to identify the genetic susceptibility factors that can
be used as candidates in genotype-phenotype studies.
MATERIALS AND METHODS
Chemicals. A set of 14 chemicals includes model chemicals representing
a wide range of classes of toxicants. Chemicals were obtained from the U.S.
Environmental Protection Agency National Center for Computational Toxicology
and dissolved in dimethyl sulfoxide (DMSO) to a stock concentration of 20mM,
aliquoted to a 96-well plate, and stored at 20C. Chemical concentrations for
in vitro experiments were chosen from the reports in the literature. Dilutions
(1003) were prepared using dimethyl sulfoxide according to the necessary
final concentration, and a 96-well working plate was kept at room temperature
for no longer than 10 days. The 96-well treatment plates were prepared by
aliquoting 1 ll each of 14 chemicals at three concentrations (with a replicate of
each concentration) using Biomek 3000 (Beckman Coulter, Fullerton, CA)
robot. Wells containing vehicle alone (1% final concentration), cells in vehicle,
and a positive control (tetraoctyl ammonium bromide) were also included.
Final chemical concentrations and plate design are shown in Supplementary
figure 1.
Cell lines and culture conditions. A panel of 87 immortalized human
lymphoblast cell lines from the CEPH trios assembled by the HapMap
Consortium was purchased from Coriell Cell Repository (Camden, NJ). Each
of the CEU trios consists of a family of two parents and one child. Cell lines
were cultured as a suspension in RPMI 1640 media (Gibco, Carlsbad, CA)
supplemented with 15% Fetal Bovine Serum (HyClone, South Logan, UT) and
1% Pen-Strep (Gibco) as recommended by Coriell and maintained at 37C and
5% CO2. Cell density and viability were assessed prior to treatment using
Cellometer Auto T4 Plus (Nexcelcom Bioscience, Lawrence, MA). Cells were
grown to a concentration of 106 cells per milliliter, volume of at least 12 ml,
and viability of at least 85% before treatment. Cells (100 ll containing 104
cells) were aliquoted to each well in a 96-well treatment plate (following
addition of the chemicals, see above) and mixed using the Biomek 3000 robot.
Plates were incubated for 24 h after treatment at 37C and 0.5% CO2.
Cell viability and caspase-3/7 assays. Following a 24-h incubation period,
Cell-Titer-Glo Luminescent Cell Viability and Caspase-Glo 3/7 (Promega
Corporation, Madison, WI) assays were used according to manufacturer’s
protocol. These assays assess ATP production, a marker of cell viability, and
caspase-3/7 activity, a measure of apoptosis. Luminescence was measured and
recorded using DTX880 (Beckman Coulter) plate reader. Replicate wells at
each dose were averaged, and raw values were normalized relative to the
baseline (cells in vehicle) and background (vehicle only) at each dose. These
normalized percentage of control values were used in all subsequent analyses.
A subset of replicate cell viability (18 cell lines) and caspase-3/7 (31 cell lines)
experiments were performed independently to evaluate experimental variabil-
ity. Raw data are publicly available from PubChem (AID: 1976).
Receiver operating characteristic curve analysis and response
classification. Values from the replicate experiments were used to determine
experimental variability of chemical-elicited responses for each assay.
Although the data are inherently quantitative, it is useful to develop thresholds
for classification of individual cell lines as ‘‘responders’’ and ‘‘nonresponders.’’
The interplate replicated values (‘‘first run’’ and ‘‘second run’’) provide a useful
comparison to establish thresholds to maximize reproducibility. Briefly, for
each of the 14 chemicals, a threshold was applied to the quantitative response
for the second run and used to provisionally classify individuals as responders/
nonresponders. By comparing these provisional dichotomized values to the
original quantitative response values for the first run, a receiver operating
characteristic (ROC) curve analysis can be used as a measure of correspon-
dence. Here the dichotomized response values serve the role of ‘‘true negative/
positive’’ classification in the ROC calculation, although it should be
recognized that our purpose is different than for typical ROC analysis. Each
threshold resulted in a different ROC curve and an accompanying area
underneath the curve. By examining various possible thresholds, we found the
assay response value that gave the largest area underneath the ROC curve,
and this value was used as the response/nonresponse threshold applied to the
plate- and replicate-averaged response (see Supplementary table 1).
Estimation and testing of heritability. Heritability estimates for parent-
child trios follow from a standard quantitative trait model: y ¼ b0 þ b1 (am þ
ap) þ e for normalized ATP or caspase-3/7 phenotypes y as an average across
plate and replicate measurements (see, e.g., similar expressions in Roy-Gagnon
et al., 2008), where am and ap represent the separate maternal and paternal
allelic contributions across all contributing loci, i.e., the polygenic effects. The
normal error terms e were assumed to be independent across individuals. We
did not include an extra family-specific environmental term, reasoning that the
above model would potentially slightly overestimate heritability, and any
apparently significant results would be subject to additional scrutiny and
modeling. A straightforward variance component approach implemented in R
(v. 2.10.1) fits each family separately as multivariate normal, with fixed effect
mean b0, overall variance r2g þ r2’ (the genetic and error variances),





between parents and children. A likelihood ratio (LR) statistic with 1 degree of





>0. The positive constraint on the variance term implies
that 2log(LR) is approximately distributed as a mixture of 0 and v21, and
this approximation was used to obtain p values. The suitability of this
approximation for a sample size of 30 trios was confirmed via additional
simulations (data not shown).
Modeling of cell line, plate, and replicate effects. The availability of
multiple plate measurements on a subset of individuals enabled dissection of
the variance components because of each of the cell line, plate, and replicate
effects for each chemical and each of the normalized ATP and caspase
measurements. For the ATP assay, 16 cell lines and 34 plates were used for this
modeling, with 2 plate replications for 14 cell lines and 3 plate replications for
2 cell lines. For the caspase-3/7 assay, 20 cell lines and 50 plates were used
for this modeling, with 2 plate replications for 13 cell lines, 3 plate replications
for 4 cell lines, and 4 plate replications for 3 cell lines. Using the terminology
‘‘north’’ and ‘‘south’’ to represent the upper and lower positions of replicates on
the same plate (Supplementary fig. 1), we used the lme4 function in R v. 2.10.1
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, for the ith replicate within
plate (i ¼ 2 corresponding to south), the jth plate, and the kth cell line. Here
b0 is a fixed intercept term, and b1 is a fixed position effect, to account for





contributions from (replicate) error, plate, and cell line, respectively. Although
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the b1 term was significant for many chemicals, removal of the term did not
appreciably affect the variance components (not shown). The models did
not use family relationship information, as the heritability values were not
significant, and the inclusion of the relationship information (which largely
affects correlation structure in the error terms) would not appreciably change
the estimates.
For the genome-wide scans, a single phenotype measurement was used by
averaging across the plates and north/south replicates. The modeling approach
described above can then be used to estimate the proportion of variability due to
cell line for each assay and chemical. We have the new model for the kth cell
line yk ¼ b0 þ b0k þ ’k , where yk is the average assay value across north/south
replicates and available plates and b0k is a random intercept with variance





¼ r23, regardless of plate replication, and for cell lines with r plate
replicates (r ¼ 1, 2, 3, or 4), we have var

yk





proportion of variation due to cell line for the averaged phenotype is, finally,
var(b0k)/var(yk), where the denominator is averaged over the number of
replications.
Genome-wide association study. Genotypes for the cell lines were
obtained from phase II genotypes of the International HapMap Project (Frazer
et al., 2007). Quantitative transmission disequilibrium testing was applied to
evaluate the association between genetic markers and chemical-elicited ATP
production and caspase-3/7 activation response phenotypes using PLINK
(Purcell et al., 2007). For this analysis, quantile normalization was used on the
assay response values to reduce the influence of extreme observations. The
University of California-San Cruz Genome Browser (http://genome.ucsc.edu/
index.html) (Kent et al., 2002) NCBI Build 36.1 was utilized for examination
of genomic loci of interest. To investigate networks related to genes of interest,
we used Ingenuity Pathway Analysis Software (http://www.ingenuity.com;
Ingenuity Systems, Mountain View, CA).
RESULTS
Interindividual Variability
We successfully screened 85 cell lines for cell viability and
83 cell lines for caspase-3/7 activity endpoints. These assays
were selected based on their utility for in vitro screening of
cytotoxicity in cell type- (Xia et al., 2008) and individual-
independent manner (Choy et al., 2008). A combination of the
two assays compensates for the limitations of the individual
assays and therefore can provide sensitive and reliable
estimation of cytotoxicity (Shi et al., 2010).
Using ‘‘on the plate’’ duplicates and a subset of independent
replicate experiments (containing duplicate wells for each
chemical/concentration), we determined the extent of experi-
mental variability. The thresholds established using this
analysis (see Materials and Methods section and Supplemen-
tary table 1) were used to classify responder/nonresponder
cell lines for each chemical and assay. Among the chemicals
screened in this study, there was a range of interindividual
variability in cytotoxicity across the population of cell
lines. Even though three concentrations were tested for
each chemical in all cell lines and assays, only the highest
concentrations elicited robust responses (data not shown),
and further analyses were performed on top concentrations.
For cell viability assay, the intraplate correlations between
responses to 14 chemicals (rPearson ¼ 0.80 ± 0.17, rSpearman ¼
0.68 ± 0.22) were generally higher than interplate correlations
(rPearson ¼ 0.65 ± 0.28, rSpearman ¼ 0.55 ± 0.23). For caspase-3/7
assay, the intraplate correlations (rPearson ¼ 0.89 ± 0.17,
rSpearman ¼ 0.64 ± 0.14) were as high as or even lower than
those in interplate comparisons (rPearson ¼ 0.88 ± 0.13,
rSpearman ¼ 0.73 ± 0.16).
Interindividual (i.e., between cell lines) variability in
responses was observed for some, but not all, chemicals in
the panel of 14. For each chemical/assay, we used random-
effect modeling to determine the portions of the variability due
to cell line, plate replicates, and within-plate replicates (see
Materials and Methods section and Supplementary tables 2A
and 2B). The results indicate substantial portions of variability
because of cell line for some chemicals, keeping in mind that
the initial modeling reflected portions of variability for each
measurement, not considering the impact of averaging across
replicates. When the impact of replicate averaging is
considered (Supplementary tables 2A and 2B), the proportion
of variation because of cell line is even higher, ranging from 15
to 40% for several assay/chemical combinations. The averaged
phenotype values are reflective of the individual ‘‘phenotype’’
value used for later association analysis, and such fractions of
explained variability compare quite favorably to the cumulative
effect size distributions for modern genome-wide association
study data sets (Park et al., 2010), although additional
heritability investigation is warranted. Basal values for each
of the assays tended to be correlated with the response values at
the highest dose; thus, the analysis using normalized values
was key to eliminate potentially spurious correlation because of
the baseline differences between cell lines.
Representative examples of trends in responses that were
seen across the population of cell lines are shown in Figure 1.
The cell viability (ATP production) response (Fig. 1A) was
most variable for perfluorooctanoic acid (PFOA) (100lM) and
phenobarbital (3mM), and there is correlation between the two
on the individual cell line level. At the same time, the loss of
cell viability induced by rifampin (100lM) was very consistent
across the panel. Induction of apoptosis (activation of caspase-
3/7) phenotype (Fig. 1B) was most variable with phenobarbital;
however, PFOA and propiconazole (100lM) did exhibit some
but not as wide a range of responses.
Population-Wide Variability
Next, we assessed the ranges of variability in the popula-
tion that were exhibited by the chemicals tested. Varying
degrees of population-wide variability were exhibited in both
phenotypes in response to the panel of 14 chemicals (Figs. 2A
and 2B). Most of the chemicals tested showed rather narrow
ranges of variability and little overall effect, except for PFOA
and phenobarbital. The number of responder cell lines (see
Materials and Methods section for a description of the
classification) is shown in Figures 2C and 2D. Rifampin,
myclobutanil (100lM), and propiconazole caused a robust
decrease in ATP production (loss of cell viability) in half or
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more of the cell lines even though there was little population-
wide variability. Polychlorinated biphenyl-118, PFOA, and
phenobarbital had an opposite effect on the ATP production
phenotype. It has been reported previously that some
cytotoxic treatments may lead to a transient increase in the
intracellular ATP, an effect attributed to enhancement in
energy production when cells are undergoing self-repair in
response to toxic challenge shortly after exposure (Shi et al.,
2010). Propiconazole, and phenobarbital also caused the most
increases in activation of caspase-3/7, even though the
fraction of responder cell lines was much smaller, only 10–
20%. Interestingly, whereas rifampin exhibited a uniform
effect of loss of ATP production in this panel of cell lines and
thus produced the highest number of responders, chemicals
that showed great variability in responses (e.g., PFOA,
phenobarbital, and propiconazole) also elicited a number of
robust responses in both assays. It should be noted that
cytotoxicity was observed in at least one individual in
response to most of the chemicals (except for mono-ethyl-
hexyl phthalate, PFOA, and perfluorooctanesulfonic acid for
the ATP assay, and di-ethyl-hexyl phthalate and diethyl ether
for the caspase-3/7 assay), further arguing for the utility of
screening in a genetically diverse panel of cells whereby both
the population-wide and the individual’s responses can be
evaluated.
Comparison of Chemical-Elicited Responses
Similarities and/or differences in response to chemicals
in two assays probing divergent modes of cell death in
a population may provide additional clues for mode of action
analysis. We compared compound effects both within and
between assays by calculating correlations between compounds
with respect to their population-wide effects. A heat map
(Fig. 3) of Spearman correlation coefficients (see sidebar scale
for reference) shows that strong concordance of responses
across a population exists for some chemicals known to have
similar modes of action (or a parent-metabolite pair) within
each assay. However, some closely related chemicals, such as
PFOA and perfluorooctanesulfonic acid, did not elicit highly
similar responses within either assay. In addition (as is also
shown on Fig. 1), responses to PFOA and phenobarbital were
highly correlated in the ATP production assay, but not in the
caspase-3/7 assay. Correlation of compound’s activity between
the two assays was also calculated; yet, no significant
correlations between chemical-elicited responses in ATP
production and caspase-3/7 activity were found (data not
shown).
In addition to evaluating similarities in responses across
chemicals, we assessed similarities among cell lines in the
population. Correlations between responses to the 14 com-
pounds in these cell lines were evaluated and unsupervised
clustering performed (average linkage hierarchical clustering
using the correlation metric) using the data from ATP
production (Fig. 4A) and caspase-3/7 activation (Fig. 4B)
assays. Similar to the observations in Figure 3, chemicals of the
same class showed similar responses and clustered together.
Across the individual cell lines, subclusters of response are
apparent; however, no familial clustering of cell lines was
evident for responses to this panel of chemicals.
As a more formal approach to assess the impact of familial
relationships, we performed variance components heritability
testing in the trios for each chemical/assay (see Materials and
Methods section and Supplementary table 3). None of these
results was significant, an observation which is consistent with
informal examination of mid-parent assay values compared
with those of the offspring (data not shown).
Phenotype-Genotype Association Mapping
The cell-based model system used in this study is not only
genetically diverse but is also genetically defined, with dense
genotyping information (several million single nucleotide
polymorphisms [SNPs]) publicly available (Frazer et al.,
2007). Thus, it is possible to examine associations between
the chemical-induced phenotypes (ATP production and
caspase-3/7 activity) and the genetic markers, investigating
potential genetic contributions to the observed variability in
responses. Although phenotype-genotype relationships were
assessed using genome-wide association scans (see Materials
and Methods section ) on all chemical/assay combinations,
we report here a detailed analysis of the effect of PFOA
FIG. 1. Interindividual variability in response to toxicants in a panel of
human lymphoblast cell lines. Production of ATP (A) and activation of
caspase-3/7 (B) were assessed 24 h after treatment with phenobarbital
(s, 3000lM), PFOA (h, 100mM), rifampin (:, 100lM), or propiconazole
(e, 100lM). Percent change over the baseline (vehicle, 1% DMSO) in each
cell line is shown. Cell lines are ordered (in each panel separately) according to
the response to phenobarbital. Cell lines were considered responders (filled
symbols) if percent change was exceeding the significance threshold (see
Materials and Methods section ).
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in ATP production (cell viability) assay. PFOA elicited the
widest range of interindividual variability in this phenotype,
with close to 35% of cell lines classified as responders,
across the population of cells. Both pharmacokinetics and
toxicity of PFOA are known to be highly variable in many
species, as evidenced, e.g., by studies with controlled
exposures in nonhuman primates (Butenhoff et al., 2002). In
addition, PFOA was estimated to exhibit approximately 20%
variation due to cell line for the averaged response (Supple-
mentary table 2), although as described earlier there was no
significant evidence of heritability. In such circumstances, the
power to detect significant associations is likely to be limited,
but a genome scan for these samples can nonetheless be
performed as the genotypes of these cell lines are publicly
available, potentially identifying candidate regions for follow-
up analyses.
The genome-wide plot in Figure 5A shows ~2.2 million
SNPs and their strengths of association with PFOA-elicited
ATP production phenotype. Using a genome-wide threshold of
p < 106 as suggestive evidence identifies loci on chromo-
somes 4 (Fig. 5B) and 14 (Fig. 5C). Within the 500-kb loci
flanking SNPs with highest association, there are several
potential candidate genes for susceptibility to PFOA. On
chromosome 4, FAT tumor suppressor homolog 1 (FAT1) is
a human gene whose homolog in the rat has been shown to
be responsive to PFOA treatment (in the liver) (Guruge et al.,
2006). On chromosome 14, three genes were located in
the candidate quantitative trait locus (QTL): solute carrier
family 24 (sodium/potassium/calcium exchanger), member 4
(SLC24A4); cleavage and polyadenylation specific factor 2
(CPSF2); and Ras and Rab interactor 3 (RIN3). SLC24A4 is
a sodium ion carrier, and numerous genes from the solute ion
carrier family have been identified as responsive to PFOA
treatment in rat liver, rat kidney, and mouse liver (Guruge
et al., 2006; Kudo et al., 2002; Rosen et al., 2007). Although
CPSF2 and RIN3 have not been shown in previous studies to
be responsive to treatment with PFOA, they are tightly linked
through a gene network to genes that have been observed as
responsive to PFOA treatment in other species. Networks for
CPSF2 (Fig. 5D) and RIN3 (Fig. 5E) show the interactions
with immunoglobulin heavy constant mu and RAB5A/B,
member of RAS oncogene family (RAB5A and RAB5B),
respectively, which are responsive to PFOA in rat and chicken
liver (Guruge et al., 2006; Yeung et al., 2007).
DISCUSSION
Although the utility and relevance of the cell-based models
with regard to species, metabolism capacity, concentration
selection, and other important factors are still under intense
debate (Coecke et al., 2006; Hartung and Daston, 2009),
FIG. 2. Population-wide variability in response to 14 model toxicants. Production of ATP (A and C) and activation of caspase-3/7 (B and D) in a panel of
human lymphoblast cells were assessed 24 h after treatment with the highest dose (see Supplementary fig. 1) of each compound. Box and whiskers plots (A and B)
were used to exhibit the variability in responses across the population. Bar graphs (C and D) demonstrate the number of cell lines with a significant response above
(light bars) or below (dark bars) the vehicle control.
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high-throughput in vitro screening methods are destined to
become the major means for addressing numerous gaps in
chemical toxicity data (Andersen and Krewski, 2009). One
important dimension that is yet to be comprehensively
considered in chemical testing is the role of the genetic
variability that plays a major role in differential susceptibility to
chemicals. Indeed, an in vitro model system that is genetically
defined, representative of a diverse population, and amenable to
high-throughput screening could significantly aid in chemical
prioritization, identification of susceptibility factors, population-
wide uncertainty analysis, and predictive toxicity testing.
The human population-based in vitro resource provided by
the HapMap Consortium allows generation of phenotype data
in a cell-based model system, which contains genetic in-
formation representative of a diverse human population
(Meucci et al., 2005). The toxicity data obtained in this model
system can potentially be combined with high-density
genotype information to enable the discovery of genetic causes
of susceptibility and variability in response (Watters et al.,
2004). Combining genotype and phenotype information for
both molecular profiles and complex traits is a promising
strategy for understanding which genes, pathways, and
biological processes are also under the influence of a given
QTL (Harrill and Rusyn, 2008). Additional advantages of
using HapMap LCLs are ease of experimental manipulation
and ability to control the experimental environment, allowing
the genetic contributions toward a specific chemical-induced
phenotype to be tested (Huang et al., 2007).
Some (Choy et al., 2008) have argued that nongenetic
factors for the LCL cell lines could offer alternative
explanations for cell line variability, hampering efforts to
elucidate genetic variation. Although we have taken steps to
minimize alternate sources of variation, the question will
remain open until clear genetic susceptibility variants have
been identified. The establishment of apparent cell line
variation indicates the need for caution in interpreting
a potential population-wide risk for a chemical, both because
of the potential for underlying genetic susceptibility as well as
the possibility that genomic assays performed by other
researchers on much more limited sample sets have also been
subject to such variation. Nonetheless, we point out clear
differences in the scientific goals of toxicogenetic testing
approaches compared with that of other genetic subdisciplines
(e.g., pharmacogenomics). In toxicology, merely establishing
FIG. 3. Within-assay correlation map of compound activity across the population. Correlations between compounds with respect to their population-wide
effects in the ATP production (bottom left) or caspase-3/7 activation (upper right) assays are shown as a heat map using Spearman correlation coefficient values
(see sidebar scale for reference). Only DE 71 and Rifampin (Caspase 3/7 activation) showed negative correlation.
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ranges of variability is important, both because such ranges
may reflect true underlying genetic variability but also because
they may reflect other sources of variability, the extent of
which may have gone unrecognized.
The freshly isolated lymphocytes (generally described as
peripheral blood mononucleated cells) are widely used as
a surrogate tissue for toxicity studies and as a source of DNA
for genotyping. Numerous reports in the literature have
examined the metabolic capacity of the total lymphocyte
preparations, as well as fractions of T and B lymphocytes
(Sempoux et al., 1999; Siest et al., 2008; Vanden Heuvel et al.,
1993), and their capacity for induction of the metabolism genes
by xenobiotics (Krovat et al., 2000). Whereas lymphocytes do
not have the metabolic capacity of the liver, or even that of
freshly isolated hepatocytes, they do express a number of
nuclear receptors, as well as most genes of the phase I and II
metabolism, and transporters (Siest et al., 2008). Thus, even
though the metabolism-dependent toxicity may not be detected
in cultured lymphocytes and lymphoblasts, this model system
is comparable to many other transformed cells; yet, it offers
a critical advantage of the defined genetic variability.
This study shows that data produced by testing a set of
chemicals in a genetically defined yet diverse human
population-based in vitro system can be useful in many ways.
The examination of interindividual variability shows that for
some chemicals, such as phenobarbital and PFOA, there is an
appreciable interindividual variability in response across the
population, whereas for others, such as rifampin, toxicity
response is uniform across the population. This suggests that
there is utility of using this population-based in vitro system for
FIG. 4. Correlation of responses between chemicals and individuals. Heat maps were generated by clustering (average linkage on the correlation metric) the
data on percent ATP production and percent caspase activation at highest dose across all chemicals and individuals. The heat maps are ordered both vertically and
horizontally with the most correlated participants and chemicals being displayed near to one another. Data were mean centered and transformed as indicated in the
corresponding histograms.
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both prioritization of chemicals for more in-depth screening
(for those exhibiting great variability across the population)
and understanding the potential genetic causes of individual
susceptibility. In addition, these data represent a measure of
the degree of variability in toxicity-relevant phenotypes,
information which may be useful in defining the extent of
a population-wide uncertainty for risk assessment.
Identifying chemicals with the widest variability in response
in a genetically diverse population signifies the need to further
examine the mechanisms behind interindividual responses.
First, the comparisons of the adverse effects for a panel of
chemicals and across a population can generate hypotheses
concerning modes of action that may explain the similarities
and/or differences within the population and between chem-
icals. For example, responses to PFOA and phenobarbital were
highly correlated in the ATP production assay, but not in the
caspase-3/7 assay, indicating similarities in their modes of
action with regard to the effect on general cell metabolism and
cell proliferation, but not on the activation of apoptosis.
Second, the lack of significant correlations between chemical-
elicited responses in ATP production and caspase-3/7 activity
may indicate that none of the chemicals that we tested reduces
cell viability through the apoptotic pathway at the concen-
trations used. Third, comparing responses to chemicals across
the population is another important assessment that provides
information on population-wide effects. Lack of familial
clustering may indicate that ATP production and caspase-3/7
activation responses to chemicals in this panel of cells are not
heritable, but because of the complexity of the traits that we
observed and the small number of chemicals, concentrations,
and time points tested, further studies may be needed.
In addition, this study identified several potential candidate
susceptibility genes for PFOA-induced adverse effects. The
genes in the susceptibility loci can be linked either directly or
indirectly to the known effects of PFOA in other tissues and
species (Guruge et al., 2006; Kudo et al., 2002; Rosen et al.,
2007). Existence of previous reports from the in vivo model
systems provides biological plausibility to the discovered
associations and serves as an illustrative example supporting
the potential of using high-throughput phenotype and genotype
data from an in vitro human population-based resource to
discover genetic loci that may be relevant to observable trends
in phenotypes across the population. In addition, the candidate
regions can be further elucidated using existing expression
QTL (eQTL) data under the hypothesis that regional SNP
variants may act on susceptibility via expression-based
regulation. Whereas a search of the eQTL browser (eqtl.
uchicago.edu) found no cis-eQTL associations in the FAT1
region with the requisite evidence for display (cis-eQTL
evidence with p < 103), two SNPs (rs12586368 and
rs7159431) in intron 1 of SLC24A4 were reported as having
evidence of cis-eQTL action on transcript CCDC88 and one
SNP (rs17783660) in the exon 2 of RIN3 was reported as
having evidence of cis-eQTL action on BTBD7. All the SNPs
and transcripts are in the same 11q32 region based on the
RNA-seq data (Montgomery et al., 2010). Although the tissue
sources for examination of eQTL evidence are currently
limited, larger and richer eQTL data sets will soon be available,
with organ-specific evidence of genetic regulation of transcrip-
tion. Further studies are needed to firmly address the potential
biological role of these genes in PFOA-induced adverse effects
FIG. 5. Genome-wide association scan of ATP production response to
PFOA. (A) Genome-wide plot of SNPs and their degree of association with
PFOA-elicited ATP production phenotype. Arrows indicate the loci with
highest association. (B and C) Loci (500 kb) on chromosomes 4 and 14
flanking SNPs that are highly associated (p < 0.000001) with PFOA-elicited
phenotype. Genes located in these loci are shown as well as gene networks for
CPSF2 (D) and RIN3 (E). Shaded symbols (IGHM, RAB5A and RAB5B)
indicate genes that have been identified as responsive to PFOA treatment in rat
and chicken liver (Guruge et al., 2006; Yeung et al., 2007).
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and to test these and other candidates in human or animal
studies to verify their mechanistic relevance to interindividual
susceptibility.
It is important to consider that in vitro systems have many
limitations. Culture conditions of many cell-based in vitro
systems do not mimic physiological conditions, are not
homeostatic, and are often oxygen deprived. Cell densities
are often lower than tissue densities, impairing normal
intracellular signaling, and multiple cell types usually are not
represented, limiting cell-cell interactions. Many in vitro cell-
based systems are of cancer origin, which is problematic
because it is known that cancerous cells have thousands of
mutations and even chromosomal aberrations which can affect
phenotypes (Hartung and Daston, 2009), and these limitations
make prediction of human toxicity based on in vitro toxicity
results very challenging. The HapMap cell lines used in this
study are not devoid of many of these limitations. In addition,
the CEPH panel consists of cell lines derived from a human
population that have been immortalized via Epstein-Barr
virus transformation to induce long-term growth (Tosato and
Cohen, 2007). A concern was expressed that Epstein-Barr virus
copy number as well as cellular growth rate and ATP levels
play a confounding role in studies using these cell lines to
detect genetic contributions to phenotypic traits (Choy et al.,
2008).
Although the HapMap cell lines have important limitations,
we were able use these cell lines to generate data that can be
used for hazard identification in a population context. Our
study was limited in size and throughput but serves as an
important proof of concept that may be scaled to larger
samples. In addition, high-throughput studies should be done to
explore a wider range of chemicals and time points to
fully explore the ability of this system to provide a measure
of population-based dose-response for risk assessment
purposes. Nevertheless, our work does demonstrate that
a genetically defined, diverse in vitro model system can be
used to generate data that are useful for exploring population-
wide interindividual variability in response, chemical mode of
action characteristics, and genetic contributions to observed
phenotypes.
CONCLUSIONS
This study aimed to investigate the utility of using
a genetically defined yet diverse human in vitro model system
to screen for adverse effects of environmental chemicals.
A population of cell lines was exposed to a panel of model
toxicants, and cell viability and caspase activation were
assessed. The interpretation of the data from in vitro screening
in the population-based cell culture models, rather than
collections of unrelated cell lines from multiple species and
tissues, is affording several advantages. First, our results show
that some, but not all, chemicals elicit interindividual variation
in response to treatment. Chemicals that vary in their effects
across the population may need to be prioritized for further
testing using additional in vitro or in vivo approaches. Second,
this screening method provides a population-wide measure of
uncertainty, information which may be crucial for the future
risk assessment approaches that will rely heavily on in vitro
data (Andersen and Krewski, 2009). Third, such data may be
used to explore potential differences/similarities in modes of
action between chemicals on the population-wide level. Lastly,
by combining the toxicity data and publicly available genetic
information, it is possible to probe the contribution of genetics
to adverse phenotypes and select the candidate genes and
regulatory networks for further studies to verify their
mechanistic relevance with regard to differences in suscepti-
bility to chemical treatment.
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